GSK2983559 (compound 3) 是一种高效、特异性的，具有口服活性的受体相互作用蛋白 2 (RIP2) 激酶抑制剂，在体内和人类炎症性肠病外植体样本中，具有良好的阻断多种促炎细胞因子反应活性。
| 生物活性 |
GSK2983559 (compound 3) is a potent, specific and oral active receptor interacting protein 2 (RIP2) kinase inhibitor, which has excellent activity in blocking many proinflammatory cytokine responses in vivo and in human inflammatory bowel disease explant samples. |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 运输条件 |
Room temperature in continental US; may vary elsewhere. |
|||||||||
| 储存方式 |
|
|||||||||
| 溶解性数据 |
In Vitro:
DMSO : < 1 mg/mL (ultrasonic;warming;heat to 80°C) (insoluble or slightly soluble) H2O : < 0.1 mg/mL (ultrasonic) (insoluble) DMF : < 1 mg/mL (ultrasonic;warming;heat to 80°C) (insoluble) Ethanol : < 1 mg/mL (ultrasonic) (insoluble) *GSK2983559 is usually formulated as a suspension. |
|||||||||
| 临床试验 |
|
纯度： 98%
关注我们
获得KKL MED 最新资讯
咨询热线：
400-881-9290
Data Sheet